Nicorette Invisi (Nicotine)

Nicotine, the active ingredient in Nicorette Invisi, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It is intended for adult smokers who are attempting to quit, providing a steady dose of nicotine to lessen withdrawal symptoms and reduce cravings associated with cessation.

GNH USA supplies Nicorette Invisi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory requirements and is manufactured under GMP conditions to ensure consistent quality and safety.

Nicorette Invisi is a nicotine replacement therapy used in smoking cessation. Smoking cessation: helps reduce cravings and withdrawal symptoms in adult smokers attempting to quit. Tobacco dependence: provides controlled nicotine delivery to support cessation efforts. Relapse prevention: assists individuals who have quit smoking to maintain abstinence by mitigating occasional urges.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Sleep disturbance: vivid dreams or difficulty falling asleep. - Headache: mild to moderate intensity. - Nausea: occasional feeling of queasiness. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Significant skin rash: blistering or extensive dermatitis. - Chest pain or palpitations: may indicate cardiovascular stress. - Hypertension: unexpected rise in blood pressure. - Syncope: fainting episodes. - Unexplained weight loss: persistent loss without dietary change.

Before using Nicorette Invisi, consider the following precautions. Assess nicotine dependence: evaluate the level of smoking habit before selecting patch strength. Avoid use in non‑smokers: nicotine exposure is unnecessary for individuals who do not smoke. Do not combine with other nicotine products: concurrent use can lead to excess nicotine. Consult a healthcare professional if you have cardiovascular disease, uncontrolled hypertension, or diabetes. Store at room temperature: keep in the original packaging, protect from moisture and direct heat.

Nicorette Invisi may interact with other substances. Major Interactions (Avoid): - Other nicotine replacement therapy: increased nicotine exposure may cause toxicity. - Combined use with varenicline or bupropion: may intensify side effects such as nausea or insomnia.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be masked. - MAO‑inhibitor antidepressants: possible additive effect on blood pressure. - Caffeine: may increase jitteriness or palpitations.